GSK plc
European stocks tick higher; Luxury carmaker Mercedes up 5.7%, on pace for best trading day since 2022
Traders work, as a screen broadcasts a news conference by U.S. Federal Reserve Chair Jerome Powell following the Fed rate announcement, on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., Sept. 17, 2025. Brendan McDermid | Reuters LONDON — European stocks edged higher on Wednesday, with some stocks particularly […]
Read More
European stocks close higher as pharma giants AstraZeneca and GSK notch gains
Stocks listed in Europe closed higher on Monday, as investors monitored the impact of a potential U.S. government shutdown later in the week. The pan-European Stoxx 600 provisionally ended up around 0.34%, with most sectors and major bourses in positive territory. Lufthansa ended the session slightly higher, paring earlier gains, after it said its free […]
Read More
GSK’s Walmsley to step down early as insider Luke Miels named next CEO
Emma Walmsley, chief executive officer of GlaxoSmithKline PLC, listens during a meeting with the Coronavirus Task Force and pharmaceutical executives in the Cabinet Room of the White House in Washington, D.C., U.S. on Monday, March 2, 2020. Kevin Dietsch | Bloomberg | Getty Images GSK’s CEO Emma Walmsley will step down in December and be […]
Read More
Why Trump’s 100% drug tariffs could hit Asia and Europe very differently
Global pharmaceutical stocks sold off on Friday, as markets reacted to news of 100% tariffs on branded and patented drugs imported into the United States, but significant moves lower haven’t been across the board. While Asia Pacific-listed shares in the sector saw notable falls — with some stocks tumbling more than 5% — the reaction […]
Read More
Trump admin draws unproven link between autism and Tylenol ingredient use during pregnancy
In this photo illustration, Tylenol caplets are displayed on Sept. 22, 2025 in San Anselmo, California. Justin Sullivan | Getty Images The Trump administration on Monday drew an unproven link between autism and pregnant women’s use of acetaminophen, the active ingredient in one of the world’s most common over-the-counter pain relievers, Kenvue’s Tylenol. President Donald […]
Read More
RFK Jr.’s vaccine panel postpones vote on whether to delay babies’ first hepatitis B shot
Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine panel on Friday postponed a vote on whether to delay the first dose of the hepatitis B shot from birth to at least one month for most babies born in the U.S. The decision means that the committee’s current recommendation – that all infants […]
Read More
Trump’s drug price ultimatum sets pharma firms scrambling
Key Points A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday. President Trump sent letters to 17 major firms outlining the steps they must take to cut costs. Healthcare stocks tumbled Friday, following broader market losses as investors digested Trump’s amended tariffs. Pharmaceutical firms are scrambling to respond […]
Read More
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, David Sacks, AI & Crypto Czar and Amy Gleason, Acting Administrator, Department of Government Efficiency (DOGE) attend the “Making Health Technology Great Again” event in the East Room […]
Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]
Read More
FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option
The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could help bring the world closer to ending the decades-long epidemic […]
Read More